The Effect of Rosuvastatin on Markers of Immune Activation in Treatment-Naive Human Immunodeficiency Virus-Patients

Open Forum Infectious Diseases
Robyn G M WeijmaWillem L Blok

Abstract

Background.  Immune activation has been implicated in the excess mortality in human immunodeficiency virus (HIV)-infected patients, due to cardiovascular diseases and malignancies. Statins may modulate this immune activation. We assessed the capacity of rosuvastatin to mitigate immune activation in treatment-naive HIV-infected patients. Methods.  In a randomized double-blind placebo-controlled crossover study, we explored the effects of 8 weeks of rosuvastatin 20 mg in treatment-naive male HIV-infected patients (n = 28) on immune activation markers: neopterin, soluble Toll-like receptor (TLR)2, sTLR4, interleukin (IL)-6, IL-1Ra, IL-18, d-dimer, highly sensitive C-reactive protein, and CD38 and/or human leukocyte antigen-DR expression on T cells. Baseline data were compared with healthy male controls (n = 10). Furthermore, the effects of rosuvastatin on HIV-1 RNA, CD4/CD8 T-cell count, and low-density lipoprotein cholesterol were examined and side effects were registered. Results.  T-cell activation levels were higher in patients than in controls. Patients had higher levels of circulating IL-18, sTLR2, and neopterin (all P < .01). Twenty patients completed the study. Rosuvastatin increased the CD4/CD8 T-cell ratio (P = .02). No ...Continue Reading

References

Jun 10, 2004·Atherosclerosis·Thomas FehrPeter Ammann
Mar 18, 2006·Clinical and Experimental Immunology·W SongJ Tang
Sep 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Norbert BlankHanns-Martin Lorenz
Dec 29, 2007·The Journal of Pathology·V Appay, D Sauce
Jul 3, 2008·JAMA : the Journal of the American Medical Association·Krishnan BhaskaranUNKNOWN CASCADE Collaboration
Jul 23, 2008·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Charlotte LewdenUNKNOWN ANRS EN19 Mortalité Study Group and Mortavic1
Aug 14, 2008·Pharmacogenetics and Genomics·Conrad P Hodgkinson, Shu Ye
Oct 24, 2008·PLoS Medicine·Lewis H KullerUNKNOWN INSIGHT SMART Study Group
Oct 25, 2008·Annual Review of Medicine·Daniel C DouekRichard A Koup
Nov 14, 2008·AIDS·Andrew N PhillipsJens D Lundgren
Jun 19, 2013·Immunological Reviews·Mirko Paiardini, Michaela Müller-Trutwin
Nov 21, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nicholas T FunderburgGrace A McComsey
Dec 17, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Nicholas T FunderburgGrace A McComsey

❮ Previous
Next ❯

Citations

Jul 30, 2019·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Simon B AscherMichelle M Estrella
Aug 12, 2017·Current Opinion in HIV and AIDS·Virginia A Triant, Steven K Grinspoon
May 29, 2018·Current Infectious Disease Reports·Mosepele MosepeleVirginia A Triant
Apr 30, 2016·AIDS Research and Therapy·Gabriella d'EttorreVincenzo Vullo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.